Cloudbreak Pharma Postpones 2026 Annual General Meeting to 26 June

Bulletin Express
05/20

Cloudbreak Pharma Inc. (HKEX: 02592, “Cloudbreak-B”) has rescheduled its forthcoming Annual General Meeting, originally set for 29 May 2026, to 26 June 2026.

The Board cited the need for additional preparation time as the sole reason for the postponement. All other information contained in the company’s Annual Report for the year ended 31 December 2025 remains unchanged.

As of 20 May 2026, the Board comprises nine directors: • Executive Directors: Dr. Ni Jinsong (Chairman and CEO), Mr. Dinh Son Van, Dr. Yang Rong • Non-Executive Directors: Dr. Li Jun Zhi, Mr. Cao Xu, Mr. Xia Zhidong • Independent Non-Executive Directors: Ms. Nie Sijiang, Mr. Ma Yiu Ho Peter, Mr. Lee Alex Jao Jang

No further amendments to corporate schedules or disclosures were announced.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10